|
Global HER2 Positive Breast Cancer Trial Opens in NJ
New Jersey's only NCI-designated Comprehensive Cancer Center is taking part in a worldwide clinical trial targeting HER2 positive breast cancer, which accounts for up to 25 percent of all breast cancers.
More... |
| All times are GMT -7. The time now is 11:29 PM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2026, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021